Lidocaine topical - Crescita Therapeutics

Drug Profile

Lidocaine topical - Crescita Therapeutics

Alternative Names: Lidocaine topical spray - Crescita Therapeutics; NRI-ANA

Latest Information Update: 18 May 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nuvo Research
  • Developer Crescita Therapeutics
  • Class Acetanilides; Analgesics; Class Ib antiarrhythmics; Local anaesthetics; Nonsteroidal anti-inflammatories; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 18 May 2016 Chemical structure information added
  • 12 May 2016 Discontinued - Phase-I for Pain in Canada (Topical)
  • 05 Oct 2015 Lidocaine topical is available for licensing as of 20 Aug 2015. http://www.nuvoresearch.com/
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top